Why it matters:
These domestically developed innovations aim to reduce dependency on imports, meet critical industrial and medical needs, and position Iranian technology in international markets.
The big picture:
The event, attended by the Vice President for Science and Technology and key industry leaders, highlighted the capabilities of Iran’s innovation ecosystem, with a focus on companies based in Pardis Technology Park.
Key points:
Sirolimus (Zist Takhmir Co.): An immunosuppressive drug used to prevent organ transplant rejection and to treat rare diseases such as lymphangioleiomyomatosis (LAM) and benign tumors in tuberous sclerosis patients.
Ofnib (SanaPharmed Co.): A tyrosine kinase inhibitor that reduces inflammation and lung fibrosis. It is used for idiopathic pulmonary fibrosis (IPF), non-small cell lung cancer (adenocarcinoma type), and scleroderma-related lung disease.
Phenolic Novolac Resin (Resitan Co.): Used as a binder in the production of high-temperature refractory bricks for industrial furnaces, offering a domestic alternative to imported materials such as magnesite.
Smart Electro-Pneumatic Positioner (Vira Control Co.): An advanced industrial device that ensures precise valve control in oil and gas operations, improving efficiency and reliability.
Central Train Control System (Sepna Co.): An AI-powered platform with image processing and IoT integration that enhances rail safety by analyzing driver behavior, monitoring tracks, and providing real-time alerts and analytics to control centers.
Go deeper:
Tehran University Researchers Co Author Chapters in Global Energy Systems Book
Neda Sajjadi - Neda Sajjadi
